External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ERS 2026

-
Coming soon
09:00 AM
Duration 75mins Barcelona, Spain
The efficacy of astegolimab on COPD hospitalisations: Data from the Phase IIb ALIENTO and Phase III ARNASA trials
MeiLan K. Han

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:15 AM
Duration 5mins Barcelona, Spain
The efficacy of astegolimab on COPD hospitalisations: Data from the Phase IIb ALIENTO and Phase III ARNASA trials
MeiLan K. Han

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:30 AM
Duration 90mins Barcelona, Spain
COPD disease trajectories and impact of GOLD E: Danish nationwide cohort study
Anders Løkke

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:15 PM
Duration 75mins Barcelona, Spain
Clinical burden and disease trajectories of newly diagnosed COPD: a real-world retrospective analysis of German insurance claims data
Kathrin Kahnert

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:25 PM
Duration 5mins Barcelona, Spain
Clinical burden and disease trajectories of newly diagnosed COPD: a real-world retrospective analysis of German insurance claims data
Kathrin Kahnert

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:00 AM
Duration 90mins Barcelona, Spain
Exploratory eosinophil biomarker analysis from the Phase IIb ALIENTO and Phase III ARNASA trials of astegolimab in COPD
Mona Bafadhel

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 90mins Barcelona, Spain
The efficacy of astegolimab on healthcare resource utilisation– and EXAcerbation of Chronic pulmonary disease Tool– (EXACT) defined COPD exacerbations
Ethan Ashby

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:30 AM
Duration 90mins Barcelona, Spain
Astegolimab reduces sedentary time in patients with COPD: post-hoc analyses from the ALIENTO wearable device–derived physical activity substudy
Neil J. Greening

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar